| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ADA
|
adenosine deaminase
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIRE
|
autoimmune regulator
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPTL6
|
angiopoietin-like 6
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
ANXA11
|
annexin A11
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APOA1
|
apolipoprotein A-I
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
AR
|
androgen receptor
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BHLHA9
|
basic helix-loop-helix family, member a9
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C3
|
complement component 3
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CALB2
|
calbindin 2
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CBX2
|
chromobox homolog 2
|
|
CCND1
|
cyclin D1
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CERS6
|
ceramide synthase 6
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CHGB
|
chromogranin B
|
|
CILP2
|
cartilage intermediate layer protein 2
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CNDP1
|
carnosine dipeptidase 1 (metallopeptidase M20 family)
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRY1
|
cryptochrome circadian clock 1
|
|
CST3
|
cystatin C
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSK
|
cathepsin K
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYB5A
|
cytochrome b5 type A (microsomal)
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAOA
|
D-amino acid oxidase activator
|
|
DAOA-AS1
|
DAOA antisense RNA 1
|
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DMRT1
|
doublesex and mab-3 related transcription factor 1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ENHO
|
energy homeostasis associated
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FASN
|
fatty acid synthase
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGG
|
fibrinogen gamma chain
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXL2
|
forkhead box L2
|
|
FOXP2
|
forkhead box P2
|
|
FTO
|
fat mass and obesity associated
|
|
FUBP1
|
far upstream element (FUSE) binding protein 1
|
|
GABRA2
|
gamma-aminobutyric acid (GABA) A receptor, alpha 2
|
|
GATA4
|
GATA binding protein 4
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GHR
|
growth hormone receptor
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRN
|
granulin
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HFE
|
hemochromatosis
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXA10
|
homeobox A10
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B3
|
hydroxysteroid (17-beta) dehydrogenase 3
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IDE
|
insulin-degrading enzyme
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL17A
|
interleukin 17A
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL26
|
interleukin 26
|
|
IL6
|
interleukin 6
|
|
IL9R
|
interleukin 9 receptor
|
|
INHA
|
inhibin, alpha
|
|
INS
|
insulin
|
|
INSIG2
|
insulin induced gene 2
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
JAK2
|
Janus kinase 2
|
|
JAZF1
|
JAZF zinc finger 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KIF11
|
kinesin family member 11
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LEPQTL1
|
Leptin, serum levels of
|
|
LEPR
|
leptin receptor
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIPC
|
lipase, hepatic
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAMLD1
|
mastermind-like domain containing 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEIS1
|
Meis homeobox 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIR103A1
|
microRNA 103a-1
|
|
MIR122
|
microRNA 122
|
|
MIR124-2
|
microRNA 124-2
|
|
MIR124-3
|
microRNA 124-3
|
|
MIR155
|
microRNA 155
|
|
MIR21
|
microRNA 21
|
|
MIR27B
|
microRNA 27b
|
|
MIR9-3
|
microRNA 9-3
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NCAN
|
neurocan
|
|
ND1
|
|
|
NDRG2
|
NDRG family member 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PBX4
|
pre-B-cell leukemia homeobox 4
|
|
PCMTD1
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PER2
|
period circadian clock 2
|
|
PGAM4
|
phosphoglycerate mutase family member 4
|
|
PGR
|
progesterone receptor
|
|
PHF1
|
PHD finger protein 1
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLEKHA7
|
pleckstrin homology domain containing, family A member 7
|
|
PLK1
|
polo-like kinase 1
|
|
POMC
|
proopiomelanocortin
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPY
|
pancreatic polypeptide
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PROS1
|
protein S (alpha)
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAB25
|
RAB25, member RAS oncogene family
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGN
|
regucalcin
|
|
RHD
|
Rh blood group, D antigen
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RORA
|
RAR-related orphan receptor A
|
|
RRP9
|
ribosomal RNA processing 9, small subunit (SSU) processome component, homolog (yeast)
|
|
RSPO1
|
R-spondin 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100B
|
S100 calcium binding protein B
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SDCCAG8
|
serologically defined colon cancer antigen 8
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPD
|
surfactant protein D
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHOX
|
short stature homeobox
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC6A2
|
solute carrier family 6 (neurotransmitter transporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLX4IP
|
SLX4 interacting protein
|
|
SMAD4
|
SMAD family member 4
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOST
|
sclerostin
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRY
|
sex determining region Y
|
|
ST18
|
suppression of tumorigenicity 18, zinc finger
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STK11
|
serine/threonine kinase 11
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
TAC3
|
tachykinin 3
|
|
TACR1
|
tachykinin receptor 1
|
|
TACR3
|
tachykinin receptor 3
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM43
|
transmembrane protein 43
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TTC12
|
tetratricopeptide repeat domain 12
|
|
TTF1
|
transcription termination factor, RNA polymerase I
|
|
TTR
|
transthyretin
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
UGT2B28
|
UDP glucuronosyltransferase 2 family, polypeptide B28
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
USF1
|
upstream transcription factor 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VWF
|
von Willebrand factor
|
|
WDR5
|
WD repeat domain 5
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZAN
|
zonadhesin (gene/pseudogene)
|
|
ZDHHC21
|
zinc finger, DHHC-type containing 21
|
|
ZDHHC7
|
zinc finger, DHHC-type containing 7
|
|
ZFPM2
|
zinc finger protein, FOG family member 2
|
|
ZNF804A
|
zinc finger protein 804A
|
